Global Rosuvastatin Calcium Tablets Market Growth 2023-2029

Global Rosuvastatin Calcium Tablets Market Growth 2023-2029

The global Rosuvastatin Calcium Tablets market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Rosuvastatin Calcium Tablets is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Rosuvastatin Calcium Tablets is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Rosuvastatin Calcium Tablets is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Rosuvastatin Calcium Tablets players cover AstraZeneca, Sandoz, Ipr Pharmaceuticals, Inc., Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd., Zhejiang Jingxin Pharmaceutical Co., Ltd., Zhejiang Hisun Pharmaceutical Co.,Ltd., Beijing Foyou Pharma CO.,Ltd., Hinye Pharmaceutical Co., Ltd. and Reyoung Pharmaceutical Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

Rosuvastatin calcium is a prescription medicine used to treat high cholesterol (hypercholesterolemia), homozygous familial hypercholesterolemia and to slow the progression of atherosclerosis and reduce the risk of stroke and heart attack in patients with coronary heart disease risk. Rosuvastatin calcium can be used alone or with other medicines.

LPI (LP Information)' newest research report, the “Rosuvastatin Calcium Tablets Industry Forecast” looks at past sales and reviews total world Rosuvastatin Calcium Tablets sales in 2022, providing a comprehensive analysis by region and market sector of projected Rosuvastatin Calcium Tablets sales for 2023 through 2029. With Rosuvastatin Calcium Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Rosuvastatin Calcium Tablets industry.

This Insight Report provides a comprehensive analysis of the global Rosuvastatin Calcium Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Rosuvastatin Calcium Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Rosuvastatin Calcium Tablets market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Rosuvastatin Calcium Tablets and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Rosuvastatin Calcium Tablets.

This report presents a comprehensive overview, market shares, and growth opportunities of Rosuvastatin Calcium Tablets market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
5mg/tablet
10mg/tablet
20mg/tablet

Segmentation by application
Hospital
Clinic
Retail Pharmacy
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
AstraZeneca
Sandoz
Ipr Pharmaceuticals, Inc.
Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd.
Zhejiang Jingxin Pharmaceutical Co., Ltd.
Zhejiang Hisun Pharmaceutical Co.,Ltd.
Beijing Foyou Pharma CO.,Ltd.
Hinye Pharmaceutical Co., Ltd.
Reyoung Pharmaceutical Co., Ltd.
Simcere Pharmaceutical Co., Ltd.
Shandong Lukang Pharmaceutical Co., Ltd.
Shanxi Lanhua Pharmaceutical Co., Ltd.
Hunan Jiudian Pharmaceutical Co.,Ltd.
Lunan Better Pharmaceutical Co., Ltd.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Rosuvastatin Calcium Tablets market?

What factors are driving Rosuvastatin Calcium Tablets market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Rosuvastatin Calcium Tablets market opportunities vary by end market size?

How does Rosuvastatin Calcium Tablets break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.